Search arXiv⌕ Search

arXiv subjects

Clara Escorihuela-Altaba

Publications and source records attributed to Clara Escorihuela-Altaba.

2 recordsLinked to original sources

Sensitivity-driven Personalization of a Glucoregulatory Model for Digital Twin Therapeutics in Type 1 Diabetes

Digital twins are increasingly used in diabetes research, but reproducing individual glucose dynamics requires accurate identification of glucoregulatory model parameters. Traditional sensitivity analysis can identify influential parameters, yet a ranking based on limited conditions may miss parameters that matter during specific disturbances or for particular individuals. We therefore examine both the magnitude and timing of parameter influence across dynamic input-output conditions and assess whether a common ranking holds across participants. We analyze the Hovorka glucoregulatory model using data from 192 participants receiving automated insulin delivery therapy in the Type 1 Diabetes and Exercise Initiative dataset. We extend Sobol sensitivity analysis to time series and rank parameter influence under four conditions: full-day profiles, isolated meal disturbances, insulin bolus injections, and postprandial responses. We combine the condition-specific results into a global ranking and use it to select parameters for participant-specific identification. Compared with population parameters, identification restricted to the sensitivity-derived subset reduces the root mean square error of 60-minute glucose predictions by 60%, to approximately 31 mg/dL. These findings suggest that a global ranking can capture parameter influence across individuals and dynamic conditions. By narrowing the parameters requiring identification, this approach reduces computational cost and could accelerate the development of personalized diabetes digital twins.

eess.SY↗

Advanced Hybrid Automated Insulin Delivery System based on Successive Linearization Model Predictive Control: The UniBE System

Background and objective: Hybrid automated insulin delivery (hAID) systems represent the most advanced therapy for type 1 diabetes (T1D). Current systems rely on linear or linearized models of glucose homeostasis, which may compromise prediction accuracy and, in turn, timely decision-making by the controller. Physiological variability further complicates insulin requirements, underscoring the need for controllers that adapt dynamically and reduce user burden. Methods: We introduce the University of Bern (UniBE) hAID system, a framework based on successive linearization model predictive control (MPC). The controller integrates basal insulin infusion with the insulin bolus delivery module for meal-related and corrective bolus dosing, adapting bounds in real time to glucose dynamics while accounting for both automated and user-initiated inputs. In-silico evaluation was conducted using the commercial version of the FDA-accepted UVa/Padova metabolic simulator across nine scenarios involving persistent and time-varying errors in meal timing, carbohydrate estimation, and basal insulin profiles. Results: In the baseline scenario, UniBE achieved a mean time in range of 92.0+-13.2%, with time below range at 0.1+-0.2% and time above range at 7.9+-13.2%. Across perturbation scenarios, time in range remained between 75.1 and 92.8%, with low hypoglycemia incidence, demonstrating resilience to clinically relevant disturbances.

eess.SY↗